Neurología
Servicio
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (60)
2024
-
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks
Neurology, Vol. 103, Núm. 6
-
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
Trials, Vol. 25, Núm. 1
-
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I)
Revista de neurologia, Vol. 79, Núm. 1, pp. 21-29
-
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)
Revista de neurologia, Vol. 79, Núm. 2, pp. 51-66
2023
-
Characteristics of stroke units and stroke teams in Spain in 2018. Pre2Ictus project
Neurologia, Vol. 38, Núm. 3, pp. 173-180
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol
European Stroke Journal, Vol. 8, Núm. 1, pp. 380-386
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
Journal of Personalized Medicine, Vol. 12, Núm. 5
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Frontiers in Neurology, Vol. 13
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
-
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study
Neurology and Therapy, Vol. 11, Núm. 3, pp. 1101-1116
2021
-
Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente
Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268
-
Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
PLoS ONE, Vol. 16, Núm. 7 July
-
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
Neurologia, Vol. 36, Núm. 1, pp. 50-60
-
Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution
Neurologia, Vol. 36, Núm. 5, pp. 377-387
-
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
Frontiers in Immunology, Vol. 12
-
Stroke care during the COVID-19 outbreak in Spain: The experience of Spanish stroke units
Stroke and Vascular Neurology, Vol. 6, Núm. 2, pp. 267-273